Neurosteroid and neurotransmitter alterations in Parkinson's disease
- PMID: 23563222
- DOI: 10.1016/j.yfrne.2013.03.001
Neurosteroid and neurotransmitter alterations in Parkinson's disease
Abstract
Parkinson's disease (PD) is associated with a massive loss of dopaminergic cells in the substantia nigra leading to dopamine hypofunction and alteration of the basal ganglia circuitry. These neurons, are under the control, among others, of the excitatory glutamatergic and inhibitory γ-aminobutyric acid (GABA) systems. An imbalance between these systems may contribute to excitotoxicity and dopaminergic cell death. Neurosteroids, a group of steroid hormones synthesized in the brain, modulate the function of several neurotransmitter systems. The substantia nigra of the human brain expresses high concentrations of allopregnanolone (3α, 5αtetrahydroprogesterone), a neurosteroid that positively modulates the action of GABA at GABAA receptors and of 5α-dihydroprogesterone, a neurosteroid acting at the genomic level. This article reviews the roles of NS acting as neuroprotectants and as GABAA receptor agonists in the physiology and pathophysiology of the basal ganglia, their impact on dopaminergic cell activity and survival, and potential therapeutic application in PD.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis.Neuroscience. 2011 Sep 15;191:6-21. doi: 10.1016/j.neuroscience.2011.04.010. Epub 2011 Apr 15. Neuroscience. 2011. PMID: 21514366 Review.
-
GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat.Behav Brain Res. 2013 Sep 1;252:58-67. doi: 10.1016/j.bbr.2013.05.044. Epub 2013 May 30. Behav Brain Res. 2013. PMID: 23727148
-
Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.Exp Neurol. 2008 Jul;212(1):63-70. doi: 10.1016/j.expneurol.2008.03.001. Epub 2008 Mar 16. Exp Neurol. 2008. PMID: 18452916
-
Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.Neurobiol Dis. 2001 Aug;8(4):707-16. doi: 10.1006/nbdi.2001.0413. Neurobiol Dis. 2001. PMID: 11493035
-
Glutamate and Parkinson's disease.Mol Neurobiol. 1996 Feb;12(1):73-94. doi: 10.1007/BF02740748. Mol Neurobiol. 1996. PMID: 8732541 Review.
Cited by
-
A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer's Disease.Mol Neurobiol. 2024 Apr 1. doi: 10.1007/s12035-024-04135-2. Online ahead of print. Mol Neurobiol. 2024. PMID: 38558361 Review.
-
Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review.Front Psychiatry. 2023 Dec 5;14:1298359. doi: 10.3389/fpsyt.2023.1298359. eCollection 2023. Front Psychiatry. 2023. PMID: 38116383 Free PMC article. Review.
-
Human Microglia Synthesize Neurosteroids to Cope with Rotenone-Induced Oxidative Stress.Antioxidants (Basel). 2023 Apr 19;12(4):963. doi: 10.3390/antiox12040963. Antioxidants (Basel). 2023. PMID: 37107338 Free PMC article.
-
A high performance liquid chromatography tandem mass spectrometry protocol for detection of neurotransmitters in the rat brain tissue.MethodsX. 2023 Feb 18;10:102083. doi: 10.1016/j.mex.2023.102083. eCollection 2023. MethodsX. 2023. PMID: 36875344 Free PMC article.
-
[Testosterone and Alzheimer's disease].Probl Endokrinol (Mosk). 2022 Jun 24;68(5):97-107. doi: 10.14341/probl13136. Probl Endokrinol (Mosk). 2022. PMID: 36337024 Free PMC article. Russian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous